Craft

Sysmex

Stock Price

¥2.8 K

2024-10-29

Market Capitalization

¥1.8 T

2024-10-29

Revenue

¥461.5 B

FY, 2024

Sysmex Summary

Company Summary

Overview
Sysmex (シスメックス株式会社) is a company that engaged in the health care business. It specializes in development, manufacture, sale, and export or import of diagnostic instruments, reagents, and related software needed for in vitro diagnostics and providing sales and support services. The company caters to national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc.
Type
Public
Status
Active
Founded
1968
HQ
Kobe, JP | view all locations
Website
https://www.sysmex.co.jp/en/
Cybersecurity rating
ESG rating
60-79 out of 100|View all ESG data
Sectors

Key People

  • Hisashi Ietsugu
  • Yukio Nakajima

    Yukio Nakajima, Board Member, CFO, Senior Managing Director, Senior Executive Officer

    • Kaoru Asano

      Kaoru Asano, Board Member, COO, Senior Managing Director, CTO, Senior Executive Officer

      • Kenji Tachibana

        Kenji Tachibana, Board Member, COO, Senior Managing Director, Senior Executive Officer

      Operating MetricsView all

      Patent Applications

      344
      8.5%

      FY, 2017

      Patents Issued

      2.7K
      7.3%

      FY, 2018

      Countries

      190

      FY, 2018

      LocationsView all

      51 locations detected

      • Kobe, Hyogo HQ

        Japan

        Wakihama Park, 5 Chome-1-11 Iwaya Kitamachi, Nada-ku

      • Baltimore, MD

        United States

        1812 Ashland Ave #500

      • Lincolnshire, IL

        United States

        577 Aptakisic Rd

      • Mundelein, IL

        United States

        1 Sysmex Way

      • Mundelein, IL

        United States

        Two Sysmex Way

      • Sydney, NSW

        Australia

        Suite 3, Level 5/15 Talavera Rd

      and 45 others

      Sysmex Financials

      Summary Financials

      Revenue (H1, 2025)
      ¥242.5B
      Gross profit (H1, 2025)
      ¥151.7B
      Net income (H1, 2025)
      ¥25.9B
      Cash (H1, 2025)
      ¥91.7B
      EBIT (H1, 2025)
      ¥43.2B
      Enterprise value
      $1.7T

      Footer menu